Here are the local and international drugmakers also eyeing the Indian market and looking to introduce rivals to Lilly's drug ...

A delay in drug approvals in the US market remains a concern for Aurobindo. The company stated that eight ANDAs (abbreviated ...

Telangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment ...

Curateq Biologics, a wholly owned subsidiary of Aurobindo Pharma, has allotted 4,125,055 Compulsory Convertible Preference Shares (CCPSs) of Rs.10/- each to Dr. Satakarni Makkapati on 20 March 2025.

Aurobindo Pharma rose 1.82% to Rs 1,157.90 after its subsidiary, Apitoria Pharma, received an establishment inspection report (EIR) from the U.S. Food and Drug Administration for its active ...

The Nifty Pharma index closed on a positive note on Friday. Shares of Mankind Pharma Ltd.(up 7.59 per cent), Ajanta Pharma ...

Stocks like Reliance Industries, Apollo Hospitals Enterprise, Power Grid Corporation, Allied Blenders and Distillers, ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

Aurobindo Pharma has terminated its licensing agreement with Hilleman Laboratories Singapore for a paediatric pentavalent vaccine candidate, effective March 5, 2025. The company clarifies that the ...

The company isn't content with just one area of focus; it's actively expanding into new verticals like injectables, peptides, ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Hyderabad: Nearly a year and a half after its subsidiary, Auro Vaccines Pvt Ltd, inked a licensing pact with Hilleman ...